Probiodrug and VU University Medical Center in Amsterdam to Collaborate on the Development of Alzheimer’s Disease Biomarker Assays

Probiodrug Transfers its CDK9 Inhibitor Program to AstraZeneca
Probiodrug to Present at Annual BIO CEO & Investor Conference